Idebenone and Coenzyme Q10are Novel PPARα/γ Ligands, With Potential for Treatment of Fatty Liver Diseases

DMM Disease Models and Mechanisms - United Kingdom
doi 10.1242/dmm.034801
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Company of Biologists

Related search

Identification and Characterization of PPARα Ligands in the Hippocampus

Nature Chemical Biology
Cell BiologyMolecular Biology
2016English

Dissociation Constants of Ternary Complexes of Fatty Acids and Fatty Acid Amides With Horse Liver Alcohol Dehydrogenase-Coenzyme Complexes.

Acta Chemica Scandinavica
1960English

Nonalcoholic Fatty Liver Disease: Updates on Associations With the Metabolic Syndrome and Lipid Profile and Effects of Treatment With PPAR-γ Agonists

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2017English

Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2019English

P04.45. A Systematic Review of Randomized Clinical Trials on Herbal Medicines for Treatment of Fatty Liver Diseases

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2012English

Non-Alcoholic Fatty Liver Diseases and Risk of Colorectal Neoplasia

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases

Journal of Clinical Medicine
2019English

Dietary Saponins of Sea Cucumber Alleviate Orotic Acid-Induced Fatty Liver in Rats via PPARα and SREBP-1c Signaling

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

Exosomes: A Novel Strategy for Treatment and Prevention of Diseases

Frontiers in Pharmacology
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy